Corporate ActionJun 29, 2026, 07:06 AM
RedHill Biopharma Increases At The Market Offering Amount
AI Summary
RedHill Biopharma Ltd. announced it has increased the maximum aggregate offering amount under its existing At The Market (ATM) Offering Agreement. This action, formalized through a prospectus supplement filed on June 29, 2026, allows the company to issue and sell more American Depositary Shares (ADS). Each ADS represents ten thousand of its ordinary shares, under the agreement originally made with H.C. Wainwright & Co., LLC in February 2025.
Key Highlights
- RedHill Biopharma increased the maximum aggregate offering amount for its At The Market (ATM) Offering Agreement.
- The offering involves American Depositary Shares (ADS), each representing 10,000 ordinary shares.
- The prospectus supplement was filed on June 29, 2026.
- The original ATM agreement was established with H.C. Wainwright & Co., LLC on February 3, 2025.
Price Impact
More from RDHL